Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Cemiplimab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Libtayo Phase 3 Data in Adjuvant Treatment of High-Risk Carcinoma
    Libtayo Phase 3 Data in Adjuvant Treatment of High-Risk Carcinoma

    31 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/31/3091406/0/en/Libtayo-cemiplimab-Phase-3-Data-in-the-Adjuvant-Treatment-of-Post-Surgical-High-Risk-Cutaneous-Squamous-Cell-Carcinoma-CSCC-Have-Potential-to-Be-Practice-Changing.html

    GLOBENEWSWIRE
    31 May 2025
    Share Share
    BioLineRx to Present New Phase 2 Data on Motixafortide at ASCO
    BioLineRx to Present New Phase 2 Data on Motixafortide at ASCO

    30 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolinerx-announces-new-pilot-phase-data-from-phase-2-combination-trial-of-motixafortide-in-first-line-pancreatic-cancer-pdac-to-be-presented-at-asco-2025-annual-meeting-302469367.html

    PR NEWSWIRE
    30 May 2025
    Share Share
    Biohaven Shows Early Data On Trop2, FGFR3 ADCs With TopoIx
    Biohaven Shows Early Data On Trop2, FGFR3 ADCs With TopoIx

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biohaven-presents-oncology-program-updates-and-preliminary-clinical-data-showcasing-innovative-trop2-and-fgfr3-antibody-drug-conjugates-adcs-incorporating-novel-topoix-payload-with-potential-to-treat-a-wide-variety-of-tumors-302466505.html

    PR NEWSWIRE
    28 May 2025
    Share Share
    Ankyra Therapeutics reveals Phase 1 data at 2025 AACR Meeting
    Ankyra Therapeutics reveals Phase 1 data at 2025 AACR Meeting

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428550798/en/Ankyra-Therapeutics-Announces-Phase-1-Clinical-Data-at-the-2025-AACR-Annual-Meeting-and-the-first-patient-has-been-dosed-with-tolododekin-alfa-and-cemiplimab

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    Regeneron lays out bright future for newest blockbuster Libtayo
    Regeneron lays out bright future for newest blockbuster Libtayo

    05 Feb 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/regenerons-libtayo-reaches-blockbuster-status-and-has-potential-more-growth

    FIERCE PHARMA
    05 Feb 2025
    Share Share
    MAIA Biotech Announces Positive Data for THIO-101 in Lung Cancer
    MAIA Biotech Announces Positive Data for THIO-101 in Lung Cancer

    04 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250204174307/en

    BUSINESSWIRE
    04 Feb 2025
    Share Share